ArticleCureus2026
The Histopathological Spectrum of Breast Lesions in Bangladeshi Women.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective Breast lesions represent a wide clinicopathological spectrum, with breast cancer being the most common malignancy in Bangladeshi women. It often presents at a younger age and at an advanced stage, placing strain on the country's limited oncology services. This study aimed to observe the histopathological pattern of breast lesions in women attending a tertiary care center in Dhaka and to identify clinical predictors of pathologically confirmed malignant breast cancer. Methods A retrospective, hospital-based study was conducted in the Department of Pathology, Medical College for Women and Hospital, Dhaka, from June to November 2025, including 160 women with histologically confirmed breast lesions. Clinical data and histopathology reports were analyzed using descriptive statistics, chi-square/Fisher's exact tests, and multivariable logistic regression. Results The mean age was 31.79 ± 11.88 years, with most patients aged 30-39 years. The predominant diagnoses were fibroadenoma (52; 32.5%), granulomatous mastitis (24; 15.0%), invasive breast carcinoma (24; 15.0%), and fibrocystic change (13; 8.1%). Overall, 47.5% of lesions were benign, 35.6% inflammatory, and 16.9% malignant. Age ≥40 years (OR 2.582; 95% CI 1.754-3.802), bilateral involvement (OR 2.088; 95% CI 1.391-3.134), and a clinical impression of malignancy (OR 2.290; 95% CI 1.536-3.414) independently predicted malignancy. Histopathology-based classification demonstrated a sensitivity of 98.68%, a specificity of 74.07%, and an overall accuracy of 89.82% in differentiating benign from malignant lesions. Conclusions Benign and inflammatory lesions, particularly fibroadenoma and granulomatous mastitis, predominate among Bangladeshi women; however, a substantial malignant burden is evident, especially in older and bilaterally affected patients. Because the histopathology-based classification showed moderate specificity, further robust studies incorporating immunohistochemistry and molecular subtype analysis are warranted. Strengthening clinicopathological correlation and maintaining high-quality histopathology services are essential to support earlier diagnosis and targeted management in this setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.